JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219556

Anti-LYVE1 antibody [EPR21857]

4

(7 Reviews)

|

(11 Publications)

Anti-LYVE1 antibody [EPR21857] (ab219556) is a rabbit monoclonal antibody detecting LYVE1 in Western Blot, IP, IHC-P. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CRSBP1, HAR, XLKD1, UNQ230/PRO263, LYVE1, Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1, Cell surface retention sequence-binding protein 1, Extracellular link domain-containing protein 1, Hyaluronic acid receptor, CRSBP-1

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)

Immunohistochemical analysis of paraffin-embedded human colon tissue labeling LYVE1 with ab219556 at 1/20,000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on lymphatic endothelial cells of human colon (PMID : 11377291) is observed. Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat-mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)

Immunohistochemical analysis of paraffin-embedded human liver tissue labeling LYVE1 with ab219556 at 1/20,000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on blood sinusoids of human liver (PMID : 11719431) is observed. Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat-mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21857] (AB219556)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling LYVE1 with ab219556 at 1/20,000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining on lymphatic endothelial cells of human tonsil (PMID : 11377291) is observed. Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat-mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunoprecipitation - Anti-LYVE1 antibody [EPR21857] (AB219556)
  • IP

Supplier Data

Immunoprecipitation - Anti-LYVE1 antibody [EPR21857] (AB219556)

LYVE1 was immunoprecipitated from 0.35 mg of human fetal lung lysate with ab219556 at 1/20 dilution. Western blot was performed from the immunoprecipitate using ab219556 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : Human fetal lung lysate 10 μg (Input).
Lane 2 : ab219556 IP in human fetal lung lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab219556 in human fetal lung lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 20 seconds.

The band observed is consistent with the soluble LYVE1 described in the literature (PMID : 29262593; PMID : 26966180; PMID : 26926389).

All lanes:

Immunoprecipitation - Anti-LYVE1 antibody [EPR21857] (ab219556)

Predicted band size: 35 kDa

Observed band size: 50-70 kDa

true

Western blot - Anti-LYVE1 antibody [EPR21857] (AB219556)
  • WB

Supplier Data

Western blot - Anti-LYVE1 antibody [EPR21857] (AB219556)

Blocking and dilution buffer : 5% NFDM/TBST

Exposure times :

Lane 1 : 37 seconds

Lanes 2 & 4 : 92 seconds

Lane 3 : 6 seconds

Negative control : Human brain (PMID : 20599941).

Bands observed are consistent with full-length and soluble fragments, as described in the literature (PMID : 29262593, PMID : 26966180, PMID : 26926389).

All lanes:

Western blot - Anti-LYVE1 antibody [EPR21857] (ab219556) at 1/1000 dilution

Lane 1:

Human fetal lung lysate at 20 µg

Lane 2:

Human lymph node lysate at 20 µg

Lane 3:

Human fetal spleen lysate at 20 µg

Lane 4:

Human brain lysate at 20 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/100000 dilution

Predicted band size: 35 kDa

Observed band size: 50-70 kDa

true

  • Carrier free

    Anti-LYVE1 antibody [EPR21857] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21857

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/20000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-LYVE1 antibody [EPR21857] (ab219556) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of LYVE1?
Anti-LYVE1 [EPR21857] (ab219556) specifically detects a band for LYVE1 (UniProt: Q9Y5Y7) at a molecular weight of 35kDa.

Reviewed by scientists
Anti-LYVE1 [EPR21857] (ab219556) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR21857] also available for your convenience: ab219556, Carrier free - ab232935

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein "LYVE1" also known as Lymphatic Vessel Endothelial Hyaluronan Receptor 1 has a molecular mass of about 60 kDa. This protein is located on the surface of lymphatic endothelial cells. Its expression occurs mainly within the lymphatic vessels serving as an important marker for identifying lymphatic endothelium. LYVE1 facilitates the transportation of hyaluronan an important glycosaminoglycan through lymphatic vessels playing a critical role in the maintenance of extracellular matrix and tissue fluid homeostasis.
Biological function summary

LYVE1 plays a role in lymphatic system regulation and immune cell trafficking. It forms part of a network that binds hyaluronan contributing to the regulation of cell migration and adhesion. This protein interacts with molecules like CD44 and other receptors which also participate in hyaluronan binding. LYVE1's function in maintaining the balance of hyaluronan within tissues is central affecting not only the lymphatic system but also immune responses.

Pathways

LYVE1 engages in both the hyaluronan metabolism and lymphangiogenesis pathways. Its interaction with CD44 plays a significant role in the transport and uptake of hyaluronan influencing cellular processes such as proliferation and motility. These interactions link LYVE1 to pathways controlling fluid balance and immune surveillance marking it as essential for maintaining healthy lymphatic and immune function.

LYVE1 shows a connection to lymphatic-related conditions such as lymphedema and cancer metastasis. Alterations or dysregulation of LYVE1 expression can affect lymphatic function potentially leading to the accumulation of interstitial fluid as seen in lymphedema. In cancer increased LYVE1 expression can relate to tumor metastasis where it functions alongside proteins like VEGFR-3 in promoting lymphatic vessel growth and facilitating cancer cell spread.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes (PubMed : 10037799). Binds to pericelluar hyaluronan matrices deposited on the surface of leukocytes and facilitates cell adhesion and migration through lymphatic endothelium (PubMed : 26823460).
See full target information LYVE1

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:588 PubMed40759637

2025

Multi-omics prediction of axillary treatment response and tumour microenvironment alterations in lymph node-positive luminal breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Teng Ma,Zirui Wang,Zhe Zhou,Yongmei Wang,Tianyi Ma,Xiangping Liu,Yan Mao,Haibo Wang

Journal of experimental & clinical cancer research : CR 44:188 PubMed40611320

2025

Extracellular vesicle-mediated transmission of circPDLIM5 promotes lymphatic metastasis in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Tao He,Wen Tao,Jie Zhang,Tao-Lin Xia,Bin Xu,Liao-Yuan Li

Acta pharmaceutica Sinica. B 15:1143-1158 PubMed40177554

2025

Modulating active targeting nanoparticle design according to tumor progressions.

Applications

Unspecified application

Species

Unspecified reactive species

Huifang Nie,Rong Huang,Guangwei Jiang,Wenshuai Li,Lan Yang,Meng Zhang,Min Qian,Wei Guo,Tao Ye,Rongqin Huang

Discover oncology 16:180 PubMed39948247

2025

Differences in tumor angiogenesis and related factors between lung adenocarcinomas manifesting as pure ground glass opacity and solid nodules.

Applications

Unspecified application

Species

Unspecified reactive species

Rirong Qu,Yang Zhang,Shenghui Qin,Jing Xiong,Xiangning Fu,Lequn Li,Dehao Tu,Yixin Cai

Bone & joint research 13:4-18 PubMed38163445

2024

The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Wang,Zhimin Wu,Guoqiang Yan,Shan Li,Yanzhuo Zhang,Guangping Li,Chengai Wu

Journal of translational medicine 21:820 PubMed37974224

2023

YAP1/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yuling L Yang,Chu Zhou,Qi Chen,Shuzhan Z Shen,Jiandan D Li,Xiuli L Wang,Peiru R Wang

Nature communications 14:6104 PubMed37775549

2023

Photostimulation of brain lymphatics in male newborn and adult rodents for therapy of intraventricular hemorrhage.

Applications

Unspecified application

Species

Unspecified reactive species

Dongyu Li,Shaojun Liu,Tingting Yu,Zhang Liu,Silin Sun,Denis Bragin,Alexander Shirokov,Nikita Navolokin,Olga Bragina,Zhengwu Hu,Jürgen Kurths,Ivan Fedosov,Inna Blokhina,Alexander Dubrovski,Alexander Khorovodov,Andrey Terskov,Maria Tzoy,Oxana Semyachkina-Glushkovskaya,Dan Zhu

Nature communications 14:4206 PubMed37452013

2023

Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Martin Rodriguez,Brady Trevisan,Ritu M Ramamurthy,Sunil K George,Jonathan Diaz,Jordan Alexander,Diane Meares,Denise J Schwahn,David R Quilici,Jorge Figueroa,Michael Gautreaux,Andrew Farland,Anthony Atala,Christopher B Doering,H Trent Spencer,Christopher D Porada,Graça Almeida-Porada

Cellular & molecular biology letters 28:13 PubMed36803975

2023

Exosomal circ_0026611 contributes to lymphangiogenesis by reducing PROX1 acetylation and ubiquitination in human lymphatic endothelial cells (HLECs).

Applications

Unspecified application

Species

Unspecified reactive species

Wenjian Yao,Xiangbo Jia,Li Zhu,Lei Xu,Quan Zhang,Tian Xia,Li Wei

Cancer immunology research 11:405-420 PubMed36652202

2023

High-Resolution Analysis of Mononuclear Phagocytes Reveals GPNMB as a Prognostic Marker in Human Colorectal Liver Metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Nina Cortese,Roberta Carriero,Marialuisa Barbagallo,Anna Rita Putignano,Guido Costa,Fabio Giavazzi,Fabio Grizzi,Fabio Pasqualini,Clelia Peano,Gianluca Basso,Sergio Marchini,Federico Simone Colombo,Cristiana Soldani,Barbara Franceschini,Luca Di Tommaso,Luigi Terracciano,Matteo Donadon,Guido Torzilli,Paolo Kunderfranco,Alberto Mantovani,Federica Marchesi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com